Marshall Wace North America’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $91.7M | Buy |
396,689
+321,495
| +428% | +$74.3M | 0.39% | 47 |
|
|
2021
Q2 | $17.3M | Buy |
75,194
+72,456
| +2,646% | +$16.6M | 0.07% | 281 |
|
|
2021
Q1 | $512K | Sell |
2,738
-382,117
| -99% | -$71.5M | ﹤0.01% | 1164 |
|
|
2020
Q4 | $65M | Buy |
384,855
+51,841
| +16% | +$8.75M | 0.29% | 86 |
|
|
2020
Q3 | $49.3M | Buy |
333,014
+184,837
| +125% | +$27.4M | 0.32% | 76 |
|
|
2020
Q2 | $24.3M | Buy |
+148,177
| New | +$24.3M | 0.16% | 145 |
|
|
2018
Q2 | – | Sell |
-29,458
| Closed | -$2.28M | – | 1549 |
|
|
2018
Q1 | $2.28M | Sell |
29,458
-4,478
| -13% | -$346K | 0.01% | 781 |
|
|
2017
Q4 | $2.87M | Buy |
33,936
+31,139
| +1,113% | +$2.63M | 0.02% | 739 |
|
|
2017
Q3 | $241K | Sell |
2,797
-384,217
| -99% | -$33.1M | ﹤0.01% | 1159 |
|
|
2017
Q2 | $31.7M | Buy |
387,014
+329,393
| +572% | +$27M | 0.23% | 108 |
|
|
2017
Q1 | $4.84M | Buy |
+57,621
| New | +$4.84M | 0.04% | 399 |
|
|
2013
Q4 | $23.4M | Buy |
459,732
+330,471
| +256% | +$16.9M | 0.5% | 58 |
|
|
2013
Q3 | $6.51M | Sell |
129,261
-217,937
| -63% | -$11M | 0.2% | 136 |
|
|
2013
Q2 | $17.1M | Buy |
+347,198
| New | +$17.1M | 1.35% | 2 |
|